DE69219221D1 - Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten - Google Patents

Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten

Info

Publication number
DE69219221D1
DE69219221D1 DE69219221T DE69219221T DE69219221D1 DE 69219221 D1 DE69219221 D1 DE 69219221D1 DE 69219221 T DE69219221 T DE 69219221T DE 69219221 T DE69219221 T DE 69219221T DE 69219221 D1 DE69219221 D1 DE 69219221D1
Authority
DE
Germany
Prior art keywords
alkyl
chemical structure
hydroxyl
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69219221T
Other languages
English (en)
Other versions
DE69219221T2 (de
Inventor
Jean-Michel Lacoste
Jacques Duhault
Denis Ravel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69219221D1 publication Critical patent/DE69219221D1/de
Application granted granted Critical
Publication of DE69219221T2 publication Critical patent/DE69219221T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/005—Compounds of elements of Group 5 of the Periodic System without metal-carbon linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE69219221T 1991-07-03 1992-07-02 Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten Expired - Fee Related DE69219221T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919108253A FR2678622B1 (fr) 1991-07-03 1991-07-03 Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
DE69219221D1 true DE69219221D1 (de) 1997-05-28
DE69219221T2 DE69219221T2 (de) 1997-11-20

Family

ID=9414615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69219221T Expired - Fee Related DE69219221T2 (de) 1991-07-03 1992-07-02 Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten

Country Status (14)

Country Link
US (2) US5266565A (de)
EP (1) EP0521787B1 (de)
JP (1) JPH0742302B2 (de)
AT (1) ATE152113T1 (de)
AU (1) AU649849B2 (de)
CA (1) CA2072938A1 (de)
DE (1) DE69219221T2 (de)
DK (1) DK0521787T3 (de)
ES (1) ES2102478T3 (de)
FR (1) FR2678622B1 (de)
GR (1) GR3023940T3 (de)
IE (1) IE922160A1 (de)
NZ (1) NZ243418A (de)
ZA (1) ZA924966B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
ATE263770T1 (de) * 1994-02-04 2004-04-15 Smithkline Beecham Plc Verfahren zum epoxidieren prochiral olefine
US6211107B1 (en) 1994-02-04 2001-04-03 Smithkline Beecham P.L.C. Process for expoxidizing prochiral olefins and a catalyst therefor and intermediates for making the catalyst
US20020132326A1 (en) * 1995-12-15 2002-09-19 Hemmings Brian A. Process for activating a kinase
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
GB9525703D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Screening method
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5986136A (en) * 1997-04-15 1999-11-16 President And Fellows Of Harvard College Photolabeling reagent
EP0984971A1 (de) * 1997-04-24 2000-03-15 Angiotech Pharmaceuticals, Inc. Vanadiumkomplexe und deren derivate und damit verwandte herstellungsverfahren
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1872797A3 (de) * 1999-08-24 2008-04-02 Medicure International Inc. Behandlung kardiovaskulärer und verwandter Leiden
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003525303A (ja) 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド 心臓保護ホスホン酸塩およびマロン酸塩
EP1278526A2 (de) 2000-03-28 2003-01-29 Medicure International Inc. Behandlung von zerebrovaskulären erkrankungen
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US6957781B2 (en) * 2003-09-15 2005-10-25 Kraft Food Holdings, Inc. Cleaning attachment for fluid dispenser nozzles and fluid dispensers using same
EP1773370A1 (de) * 2004-07-07 2007-04-18 Medicure International Inc. Kombinationstherapien mit thrombozytenaggregations-arzneimitteln
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
KR100722795B1 (ko) 2005-12-26 2007-05-30 한국조폐공사 초근적외선을 흡수하는 이소인돌린 비대칭 사량체환 화합물및 이를 이용한 제품
GB0607096D0 (en) * 2006-04-07 2006-05-17 Imp Innovations Ltd Compound
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
JP6735163B2 (ja) * 2016-06-22 2020-08-05 株式会社Adeka バナジウム化合物、薄膜形成用原料及び薄膜の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral

Also Published As

Publication number Publication date
AU1941392A (en) 1993-01-07
JPH0742302B2 (ja) 1995-05-10
ATE152113T1 (de) 1997-05-15
GR3023940T3 (en) 1997-09-30
ES2102478T3 (es) 1997-08-01
DK0521787T3 (da) 1997-10-27
DE69219221T2 (de) 1997-11-20
CA2072938A1 (fr) 1993-01-04
US5278154A (en) 1994-01-11
AU649849B2 (en) 1994-06-02
US5266565A (en) 1993-11-30
NZ243418A (en) 1994-04-27
JPH05186481A (ja) 1993-07-27
IE922160A1 (en) 1993-01-13
EP0521787B1 (de) 1997-04-23
ZA924966B (en) 1993-03-31
FR2678622B1 (fr) 1994-11-18
FR2678622A1 (fr) 1993-01-08
EP0521787A1 (de) 1993-01-07

Similar Documents

Publication Publication Date Title
DE69219221D1 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
ES2149537T3 (es) Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma.
DK0434385T3 (da) Anvendelse af makrocycliske, nitroholdige forbindelser til behandling af retrovirale infektioner
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
DE69115768D1 (de) Chalkonderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE69202876T2 (de) Inhibitoren von N-Myristoyltransferase, deren Verfahren zur Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
DE69312984T2 (de) Substituierte Aminophosphonatderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2077070T3 (es) Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable.
ATE111912T1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
ATE86993T1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
HU9402171D0 (en) Benzopyrane derivatives process for producing them, and pharmaceutical compositions containing them
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
TH10006EX (th) พิริดาซิแนมีนที่ใช้ต่อต้านพิคอร์นาไวรัส
TH9137A (th) สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee